Insider · CIK 0001586657
John Harold Leaman
Files at TRAW (Onconova Therapeutics, Inc.). First filing -, latest -.
In brief
John Harold Leaman files SEC Form 4 as director at TRAW (Onconova Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Harold Leaman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,150 | $0.00 | $0 | 14,150 | Jul 14, 2026 |
| Mar 8, 2026 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +33,435 | $0.00 | $0 | 33,435 | Mar 10, 2026 |
| Dec 12, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Common Stock | +4,058 | $0.00 | $0 | 4,058 | Dec 16, 2025 |
| Dec 12, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to purchase)derivative | +16,234 | $0.00 | $0 | 16,234 | Dec 16, 2025 |
| Nov 21, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to purchase)derivative | +12,770 | $0.00 | $0 | 12,770 | Nov 25, 2025 |
| Oct 1, 2025 | TRAW Onconova Therapeutics, Inc. | AGrant or award Stock Option (right to purchase)derivative | +15,609 | $0.00 | $0 | 15,609 | Oct 14, 2025 |
Questions about John Harold Leaman
Answered from the filings on this page, as of the latest one.
Is John Harold Leaman buying or selling?
John Harold Leaman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Harold Leaman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Harold Leaman has 0.
Where does John Harold Leaman file Form 4?
John Harold Leaman has filed Form 4 at TRAW (Onconova Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.